IL156774A0 - Inhibitors of cruzipain and other cysteine proteases - Google Patents
Inhibitors of cruzipain and other cysteine proteasesInfo
- Publication number
- IL156774A0 IL156774A0 IL15677402A IL15677402A IL156774A0 IL 156774 A0 IL156774 A0 IL 156774A0 IL 15677402 A IL15677402 A IL 15677402A IL 15677402 A IL15677402 A IL 15677402A IL 156774 A0 IL156774 A0 IL 156774A0
- Authority
- IL
- Israel
- Prior art keywords
- inhibitors
- cruzipain
- cysteine proteases
- general formula
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0101179A GB0101179D0 (en) | 2001-01-17 | 2001-01-17 | Biologically active compounds |
US27535901P | 2001-03-13 | 2001-03-13 | |
PCT/GB2002/000184 WO2002057270A1 (fr) | 2001-01-17 | 2002-01-17 | Inhibiteurs de la cruzipaine et autres cysteines proteases |
Publications (1)
Publication Number | Publication Date |
---|---|
IL156774A0 true IL156774A0 (en) | 2004-02-08 |
Family
ID=26245571
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15677402A IL156774A0 (en) | 2001-01-17 | 2002-01-17 | Inhibitors of cruzipain and other cysteine proteases |
IL156774A IL156774A (en) | 2001-01-17 | 2003-07-03 | Inhibitors of crucifine and other cysteine proteases |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL156774A IL156774A (en) | 2001-01-17 | 2003-07-03 | Inhibitors of crucifine and other cysteine proteases |
Country Status (21)
Country | Link |
---|---|
US (2) | US7425562B2 (fr) |
EP (1) | EP1362052B1 (fr) |
JP (1) | JP4608183B2 (fr) |
KR (1) | KR100860067B1 (fr) |
CN (1) | CN1269822C (fr) |
AT (1) | ATE356130T1 (fr) |
AU (1) | AU2002219397B2 (fr) |
BR (1) | BR0206501A (fr) |
CA (1) | CA2436462C (fr) |
CY (1) | CY1106640T1 (fr) |
DE (1) | DE60218633T2 (fr) |
DK (1) | DK1362052T3 (fr) |
ES (1) | ES2281516T3 (fr) |
HK (1) | HK1060729A1 (fr) |
IL (2) | IL156774A0 (fr) |
MX (1) | MXPA03006224A (fr) |
NO (1) | NO328208B1 (fr) |
NZ (1) | NZ526913A (fr) |
PT (1) | PT1362052E (fr) |
RU (1) | RU2329266C2 (fr) |
WO (1) | WO2002057270A1 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2433520A1 (fr) | 2000-12-22 | 2002-07-04 | Axys Pharmaceuticals, Inc. | Composes et compositions en tant qu'inhibiteurs de cathepsine |
US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
WO2003024924A1 (fr) | 2001-09-14 | 2003-03-27 | Aventis Pharmaceuticals Inc. | Nouveaux composes et nouvelles compositions utiles comme inhibiteurs de la cathepsine |
WO2003042197A1 (fr) | 2001-11-14 | 2003-05-22 | Aventis Pharmaceuticals Inc. | Nouveaux composes et compositions jouant le role d'inhibiteurs de cathepsine s |
EP1546150B1 (fr) * | 2002-07-16 | 2009-03-04 | Amura Therapeutics Limited | Derives de pyrrole en tant qu'inhibiteurs de cysteine protease |
US7399765B2 (en) * | 2003-09-19 | 2008-07-15 | Abbott Laboratories | Substituted diazabicycloalkane derivatives |
WO2005066180A1 (fr) * | 2004-01-08 | 2005-07-21 | Medivir Ab | Inhibiteurs de cysteine protease |
JP2005350417A (ja) * | 2004-06-11 | 2005-12-22 | Dai Ichi Seiyaku Co Ltd | 還元的エーテル化法を用いたピロリジン誘導体の製造法 |
NZ561681A (en) * | 2005-03-21 | 2011-01-28 | Virobay Inc | Alpha ketoamide compounds as cysteine protease inhibitors |
GB0513839D0 (en) * | 2005-07-07 | 2005-08-10 | Medivir Ab | Cysteine protease inhibitors |
GB0513840D0 (en) * | 2005-07-07 | 2005-08-10 | Medivir Ab | Cysteine protease inhibitors |
GB0614052D0 (en) | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
GB0614053D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
GB0614046D0 (en) | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
GB0614042D0 (en) | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
GB0614073D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
GB0614044D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
GB0614037D0 (en) * | 2006-07-14 | 2006-08-23 | Amura Therapeutics Ltd | Compounds |
WO2008114054A1 (fr) * | 2007-03-19 | 2008-09-25 | Medivir Ab | Inhibiteurs de protéase |
US7893067B2 (en) | 2007-06-27 | 2011-02-22 | Medivir Ab | Cysteine protease inhibitors |
WO2009087379A2 (fr) * | 2008-01-09 | 2009-07-16 | Amura Therapeutics Limited | Composés |
GB0804702D0 (en) | 2008-03-13 | 2008-04-16 | Amura Therapeutics Ltd | Compounds |
GB0804701D0 (en) | 2008-03-13 | 2008-04-16 | Amura Therapeutics Ltd | Compounds |
WO2012099785A2 (fr) | 2011-01-20 | 2012-07-26 | The Regents Of The University Of Colorado, A Body Corporate | Modulateurs du complexe tlr3/arnds et leurs utilisations |
DK2891492T3 (da) | 2012-08-30 | 2022-11-21 | Univ Tokyo | Endoparasit kontrol middel |
CN106279188A (zh) * | 2016-07-21 | 2017-01-04 | 青岛科技大学 | 一种多取代呋喃并[2,3‑b]吡咯衍生物的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3652574A (en) | 1970-04-01 | 1972-03-28 | Abbott Lab | Certain 1 2 3 4 - tetrahydro-5h-pyrido (4 3-b)indoles and the corresponding 1 2 3 4-tetrahydro-9h-pyrido(3 4-b)indoles and derivatives thereof |
DZ2285A1 (fr) | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Inhibiteurs de protéase de la cystéine. |
EP0923535A4 (fr) | 1996-08-28 | 2001-01-10 | Smithkline Beecham Corp | Inhibiteurs de cysteine protease |
IL129820A0 (en) | 1996-12-23 | 2000-02-29 | Elan Pharm Inc | Cycloalkyl lactam lactone and related compounds as beta-amyloid peptide release inhibitors |
AR013079A1 (es) * | 1997-05-06 | 2000-12-13 | Smithkline Beecham Corp | Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios |
MA26618A1 (fr) | 1998-04-09 | 2004-12-20 | Smithkline Beecham Corp | Composes et compositions pharmaceutiques pour le traitement du paludisme |
CO5150165A1 (es) | 1998-11-13 | 2002-04-29 | Smithkline Beecham Plc | Inhibidores de proteasa: tipo catepsina k |
GB9911417D0 (en) * | 1999-05-18 | 1999-07-14 | Peptide Therapeutics Ltd | Furanone derivatives as inhibitors of cathepsin s |
EP1345931A2 (fr) | 2000-11-17 | 2003-09-24 | Medivir UK Ltd | Inhibiteurs de cysteine protease |
CA2433520A1 (fr) | 2000-12-22 | 2002-07-04 | Axys Pharmaceuticals, Inc. | Composes et compositions en tant qu'inhibiteurs de cathepsine |
-
2002
- 2002-01-17 CN CNB028038142A patent/CN1269822C/zh not_active Expired - Fee Related
- 2002-01-17 DE DE60218633T patent/DE60218633T2/de not_active Expired - Lifetime
- 2002-01-17 ES ES02732145T patent/ES2281516T3/es not_active Expired - Lifetime
- 2002-01-17 US US10/466,384 patent/US7425562B2/en not_active Expired - Fee Related
- 2002-01-17 EP EP02732145A patent/EP1362052B1/fr not_active Expired - Lifetime
- 2002-01-17 CA CA2436462A patent/CA2436462C/fr not_active Expired - Fee Related
- 2002-01-17 WO PCT/GB2002/000184 patent/WO2002057270A1/fr active IP Right Grant
- 2002-01-17 RU RU2003125270/04A patent/RU2329266C2/ru not_active IP Right Cessation
- 2002-01-17 MX MXPA03006224A patent/MXPA03006224A/es active IP Right Grant
- 2002-01-17 NZ NZ526913A patent/NZ526913A/xx not_active IP Right Cessation
- 2002-01-17 JP JP2002557947A patent/JP4608183B2/ja not_active Expired - Fee Related
- 2002-01-17 IL IL15677402A patent/IL156774A0/xx active IP Right Grant
- 2002-01-17 KR KR1020037009524A patent/KR100860067B1/ko not_active IP Right Cessation
- 2002-01-17 BR BR0206501-0A patent/BR0206501A/pt not_active IP Right Cessation
- 2002-01-17 AU AU2002219397A patent/AU2002219397B2/en not_active Ceased
- 2002-01-17 DK DK02732145T patent/DK1362052T3/da active
- 2002-01-17 PT PT02732145T patent/PT1362052E/pt unknown
- 2002-01-17 AT AT02732145T patent/ATE356130T1/de active
-
2003
- 2003-07-03 IL IL156774A patent/IL156774A/en not_active IP Right Cessation
- 2003-07-16 NO NO20033220A patent/NO328208B1/no not_active IP Right Cessation
-
2004
- 2004-05-14 HK HK04103421A patent/HK1060729A1/xx not_active IP Right Cessation
-
2007
- 2007-06-04 CY CY20071100742T patent/CY1106640T1/el unknown
-
2008
- 2008-09-15 US US12/211,069 patent/US20090247471A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2281516T3 (es) | 2007-10-01 |
NO20033220D0 (no) | 2003-07-16 |
HK1060729A1 (en) | 2004-08-20 |
CA2436462C (fr) | 2011-07-05 |
RU2003125270A (ru) | 2005-02-20 |
EP1362052B1 (fr) | 2007-03-07 |
DE60218633T2 (de) | 2008-02-21 |
MXPA03006224A (es) | 2004-10-15 |
CY1106640T1 (el) | 2012-01-25 |
EP1362052A1 (fr) | 2003-11-19 |
US7425562B2 (en) | 2008-09-16 |
BR0206501A (pt) | 2004-01-13 |
AU2002219397B2 (en) | 2008-02-14 |
PT1362052E (pt) | 2007-04-30 |
JP4608183B2 (ja) | 2011-01-05 |
US20090247471A1 (en) | 2009-10-01 |
KR20030075161A (ko) | 2003-09-22 |
NO20033220L (no) | 2003-09-17 |
CA2436462A1 (fr) | 2002-07-25 |
RU2329266C2 (ru) | 2008-07-20 |
JP2004518674A (ja) | 2004-06-24 |
ATE356130T1 (de) | 2007-03-15 |
NO328208B1 (no) | 2010-01-11 |
US20040138250A1 (en) | 2004-07-15 |
CN1486320A (zh) | 2004-03-31 |
DE60218633D1 (de) | 2007-04-19 |
KR100860067B1 (ko) | 2008-09-24 |
IL156774A (en) | 2008-08-07 |
NZ526913A (en) | 2004-12-24 |
CN1269822C (zh) | 2006-08-16 |
WO2002057270A1 (fr) | 2002-07-25 |
DK1362052T3 (da) | 2007-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL156774A0 (en) | Inhibitors of cruzipain and other cysteine proteases | |
TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
UA74372C2 (uk) | Інгібітори серинових протеаз, фармацевтична композиція на їх основі | |
SE0201976D0 (sv) | Novel compounds | |
BR0215405A (pt) | Composições e processos de uso de collajolie | |
DE60112974D1 (en) | Carbolinderivate | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
DE60216233D1 (en) | Carbolinderivate | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
AU2220702A (en) | Serine protease inhibitors | |
AU2001264065A1 (en) | Serine protease inhibitors | |
AU2001264081A1 (en) | Serine protease inhibitors | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
SE0101038D0 (sv) | Novel compounds | |
SE0003476D0 (sv) | Compounds | |
UA83266C2 (en) | Oxazole derivatives of tetracyclines | |
ATE287403T1 (de) | 6-phenylbenzonaphthyidine | |
DK1204659T3 (da) | Serotonerge benzofuraner | |
WO2002057246A3 (fr) | Inhibiteurs de la cruzipaine et d'autres cysteines proteases | |
EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 | |
DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
WO2002057248A3 (fr) | Inhibiteurs de la cruzipain et autres cysteine proteases | |
DK1244643T3 (da) | Tryptaseinhibitorer | |
UA85994C2 (en) | N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |